Caplacizumab-yhdp and its Use For Acquired Thrombotic Thrombocytopenic Purpura
Caplacizumab-yhdp is used in the treatment of acquired thrombotic thrombocytopenic purpura. Read the article to learn more about this drug.
Dr. Mubashir Razzaq Khan
